DataKnowledgeCloudtrainingcoordination

XC.P934 (Subject)

Taxonomy Id:

Homo sapiens

Taxonomy (Entity type)

Role Id:

cell line ancestor

Subject Role (Entity type)

Project:

LINCS

Project (Entity type)

Granularity:

cell line

Subject Granularity (Entity type)

Dcc Asset:

datapackage.zip

Processed File (Entity type)

Dcc:

LINCS

DCC (Entity type)

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC ASG003 XC.P934 24H C22 MG-132 10uM.tsv.gz File (Entity type)	A 207 KB file produced from OBI:0002965 as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 ASG003 XC.P934 24H D16 barasertib-HQPA 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 ASG003 XC.P934 24H M02 thioridazine 1.11uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 ASG003 XC.P934 24H K01 rucaparib 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 ASG003 XC.P934 24H N08 TW-37 0.74uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 ASG003 XC.P934 24H C22 MG-132 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC ASG003 XC.P934 24H H07 vemurafenib 10uM.tsv.gz File (Entity type)	A 127 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 ASG003 XC.P934 24H B06 R-547 0.12uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 ASG003 XC.P934 24H E23 nelfinavir 1.11uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC ASG003 XC.P934 24H O10 BRD-K76674262 10uM.tsv.gz File (Entity type)	A 127 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project

File

L1000 LINCS DCIC ASG003 XC.P934 24H C22 MG-132 10uM.tsv.gz

File (Entity type)

A 207 KB file produced from OBI:0002965 as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 ASG003 XC.P934 24H D16 barasertib-HQPA 10uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 ASG003 XC.P934 24H M02 thioridazine 1.11uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 ASG003 XC.P934 24H K01 rucaparib 10uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 ASG003 XC.P934 24H N08 TW-37 0.74uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 ASG003 XC.P934 24H C22 MG-132 10uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC ASG003 XC.P934 24H H07 vemurafenib 10uM.tsv.gz

File (Entity type)

A 127 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 ASG003 XC.P934 24H B06 R-547 0.12uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 ASG003 XC.P934 24H E23 nelfinavir 1.11uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC ASG003 XC.P934 24H O10 BRD-K76674262 10uM.tsv.gz

File (Entity type)

A 127 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.